Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus-Reference-Cited by-同舟云学术

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus

Published:2014 Issue:2 Volume:20 Page:168
ISSN:2287-2728
Container-title:Clinical and Molecular Hepatology
language:en
Short-container-title:Clin Mol Hepatol

Author:

Woo Hyun Young¹,Choi Jong Young²,Yoon Seung Kew²,Suh Dong Jin³,Paik Seung Woon⁴,Han Kwang Hyub⁵,Um Soon Ho⁶,Kim Byung Ik⁷,Lee Heon Ju⁸,Cho Mong¹,Lee Chun Kyon⁹,Kim Dong Joon¹⁰,Hwang Jae Seok¹¹

Affiliation:

1. Department of Internal Medicine, Pusan National University College of Medicine, Pusan, Korea.

2. Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea.

3. Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea.

4. Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

5. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

6. Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.

7. Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

8. Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea.

9. Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital, Goyang, Korea.

10. Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.

11. Department of Internal Medicine, Keimyung University College of Medicine, Daegu, Korea.

Publisher

The Korean Association for the Study of the Liver

Subject

Molecular Biology,Hepatology

Link

http://synapse.koreamed.org/pdf/10.3350/cmh.2014.20.2.168

Reference33 articles.

1. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

2. Hepatitis B virus.The major etiology of hepatocellular carcinoma

3. Chronic hepatitis B

4. Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B

5. Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous bone marrow cell transplantation in the treatment of HIV patients with compensated cirrhosis;Bioscience Reports;2020-06

Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study

;Infection and Drug Resistance;2019-04

3. Antiviral Therapy for AECHB and Severe Hepatitis B (Liver Failure);Acute Exacerbation of Chronic Hepatitis B;2019

4. Analysis of the prevalence of drug-resistant hepatitis B virus in patients with antiviral therapy failure in a Chinese tertiary referral liver centre (2010–2014);Journal of Global Antimicrobial Resistance;2017-03